Chronic Back Pain in Patients With Psoriasis, Uveitis, or Colitis: How Often Is It Axial Spondyloarthritis?August 15, 2024Psoriasis
US Experience With Infliximab Biosimilars Suggests Need for More Development IncentivesAugust 13, 2024PediatricsPsoriatic ArthritisPsoriasis
Light Therapy, Phototherapy, Photobiomodulation: New Ways to Heal With LightAugust 9, 2024Medical DermatologyPsoriasis
Management, Evaluation of Chronic Itch in Older AdultsAugust 7, 2024Medical DermatologyAtopic DermatitisPsoriasis
Advantages of a Pediatric Rheumatology/Dermatology Clinic EvaluatedJuly 30, 2024PediatricsPsoriasisAutoimmune DiseasesPsoriatic Arthritis
Study Finds Differences in Side Effect Profiles With Two Oral Psoriasis TherapiesJuly 26, 2024PsoriasisPsoriatic Arthritis
Risk of MACE Comparable Among Biologic Classes for Psoriasis, PsAJuly 26, 2024PsoriasisPsoriatic ArthritisMixed Topics
Mysteries Persist About Tissue Resident Memory T Cells in PsoriasisJuly 25, 2024PsoriasisPsoriatic Arthritis
Debate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?July 23, 2024PsoriasisAutoimmune DiseasesPsoriatic Arthritis
Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Study Finds Mace Risk Remains High in Patients with Psoriasis, DyslipidemiaJune 4, 2024PsoriasisPsoriatic Arthritis
Recent Evidence for Home Phototherapy Benefits May Improve Access for Patients with PsoriasisMay 23, 2024PsoriasisPsoriatic Arthritis
Specialists Are ‘Underwater’ With Some Insurance-Preferred BiosimilarsMay 16, 2024Business of MedicinePsoriatic ArthritisPsoriasis
Positive Phase 2 Results Reported for TYK2 Inhibitor for Patients With Moderate to Severe PsoriasisMay 3, 2024Psoriasis
Combined Pediatric Derm-Rheum Clinics Supported by Survey RespondentsApril 22, 2024PediatricsPsoriasisAutoimmune DiseasesPsoriatic ArthritisBusiness of Medicine
